Inflammation Flashcards
Glucocorticosteroids
- anti-shock
- capillary membrane permability decrease –> enhance microcirculation
- high dosage: vasoconstriction
Immunosuppression
- Cyclosporin and Tacrolimus
* Calcineurin inhibitors
Calcineurin:
- Dephosphorylates NFAT (activation)
- Translocation to the nucleus
- IL-2 expression
Mechanism:
- ONLY in T-cells
- Calcineurin inhibition
- Mastocyte inhibition, inhibition of degranulation
- Decreased IL and TNF-a expressions
Cyclosporin:
- Application: very common
- Per os with food and locally
- Indications: Autoimmune diseases, Atopic dermatitis, IBD
- Side effects: GI: vomitting, diarrhea, Alopecia, Gingival hyperplasia
Tacrolimus, Dimecrolimus:
- 500 times more active than cyclosporin
- Increased toxicity
- Topical application: 0.1 % ointment. –> Atopic dermatitis, Lupus
Pimecrolimus:
- Locally atopic dermatitis, KCS
Antihistamines
- side effects
- 1st generation: CNS depression, Anticholinergic effect
- 2nd generation: Prolonged QT interval
- appetite depression (cyproheptadine)
Antihistamines
- usage
- individual differences
- allergic diseases
- asthma, RAO?
- anaphylactic reactions?
Glucocorticoids (SAIDs)
- Side effects
- HT-hypophysis-adrenal cortex axis inhibition: approx 1-2 weeks –> cortex atrophy. Slow, continous ending
- gastric ulcers
- hepatopathy: ALKP significantly increase
- pancreatitis
- glucoma, cataracta
- thinning of skin, delayed wound healing, alopecia
- polyuria, polydypsia
- polyphagia
- muscle atrophy
- immunosuppression
Immunosuppression
- Cyclophosphamide
* Alkalytic agent
- Nitrogen mustad, DNA alkalyticing: Proliferating cells
- B-and T-cells equally effected
- GI, BM side effects: <2 G/L, whiskers
- Haemorrhagic cystitis (acrolein, Fe rare) –> Furosemide
- Mostly per. os–> Antineoplastic, Autoimmune disorders
Glucocorticosteroids
- neuroprotective effects
- Trauma –> bleeding –> local vasoconstriction
- Ischaemia –> lipid peroxidation –> ROS –> Apotosis, necrosis
Glucocorticoids conteract lipidperoxidation and enhance microcirculation
Antihistamines
- mechanism of action and classes
Mechanism of action:
- Antihistamines: inverse agonists, NOT antagonists
Classes:
1st generation:
- Ethylenediamines: Chloropyramine, chloropheniramine
- Ethanolamines: diphenhydramine, Dimenhydrinate
- Phenothiazines: promethiazines
- Piperazines: Hydroxyzine
- Other: dimetinden, cyproheptadine
2nd generation:
- Loratadine, Cetrizine, Levocetrizine
NSAIDs
- Pharmacokinetics
Absorption:
- usually weak acids
- feed (ketoprofen, carprofen/meloxicam, mavacoxib)
Distribution:
- extensive albumin binding
- hypoalbuminaemia
Metabolism:
- mostly glucoronic acid conjugation –> Feline sensitivity!
Excretion:
- urine active + inactive
Glucocorticosteroids
- antiinflammatory and immunosuppressive effects
- PLA2 (see drawing)
- COX enzyme expression decrease
- Interleukin expression (IL-1, IL-2, 3, 4, 5, 6, 10, 12) decrease
- TNF and IFN synthesis decrease
- Apoptosis in lymphocytes –> lymphocytopenia
- Neutrophilia (demargination)
JAK inhibitors
- indications, inhibits, pharmacological effect:
Veterinary: Olacitinib, Apoquel
Pharmacological effect:
- antiinflammatory, antiallergic, antipruritus
Indications:
- atopic dermatitis
Inhibits:
- Primary JAK 1
- IL-2, IL-4, IL-6, IL-13: Allergy, inflammation
- IL-31: Pruritus
Immunosuppression
- Drugs
* Usually in combination of 2 or 3
Antimetabolites:
- purine-analouges: Azathioprin, Mycophenolate-mofetil
- pyrimidine-analouges: Leflunomide
- folic acid antagonists: Methotrexate
Alkalytic agents:
- Cyclophosphamide
Glucocorticoids
Cytokine gene expression inhibitors:
- calcineurin-inhibitors: Cyclosporine, Tacrolimus, Pimecrolimus
Antihistamines:
- severe histamine release –> anaphylaxis
- vaccines, penicillins, insect bites etc
- vascular permeability –> epiglottis oedema, angiedema
- vasodilation –> shock
Other allergy mediated diseases: atopic dermatitis, cutaneous food adverse reactions, FAD
Other allergy mediated problems during surgery (eg morphine): premedication –> Acepromazine
Glucocorticoids (SAIDs)
- Pharmacological effects
- antiinflammatory
- antiallergic
- immunosuppresive
- antishock
- neuroprotective –> Glucocorticoids counteract lipidperoxidation and enhance microcirculation
Glucocorticosteroids
- systemic use
- High dosage, once
- I.V: eg shock, spinal trauma, allergy - ADT (Alternate day therapy)
- Prednisolone, methylprednisolone
- every other day
- Mornings (dog), evenings (cat) - Long acting injections (depot)
- only if ADT is not possible
Antihistamines
- pharmacokinetics
Absorption:
- good oral absorption: Cmax 2-3 hours
Distribution:
- CNS 1st generation
- 2nd generation –> ionized form + extensively albumin bound
Metabolism:
- Liver –> CYP450 inducers!
Immunosuppression
- Indications
Autoimmune diseases:
- lupus, pemphigus omplex
- IHA: immune haemolytic anemia
- KCS
Hypersensitivity disease:
- atopic dermatitis
- asthma
- IBD: inflammatory bowel disease
Transplantation
JAK inhibitors
- Pharmacokinetics
- excellent per os absorption: 90%
- Give with food
- Tmax: 1 hour
- Metabolism: Liver, CYP450 NOT influenced
NSAIDs
- Active substances - Non-acidic substanves
Anilin derivatives: Paracetamol (Acetaminophen) (Pandol, soridon, NeoCitran)
- COX-3 inhibition –> minor analgesic, antipyretic
- Never in cats –> methaemogloniaemia
Metamizole sodium (Alyopyrin A.U.V)
- COX-3, but not specific
- Never in cats
Glucocorticoids (SAIDs)
- active substances
Esters, salts:
Na phosphate, Na succinate
Diprionate, phenylpropionate, acetate –> Acetonide
Dexadreson
- Cortisol: Potency 1. Short effect
- Prednisolone: Potency 4. Medium effect
- Methylprednisolone: Potency 5-7. Medium effect
- Triamicinolone: Potency 5-10. Medium effect
- Betamethazone: Potency 25-30. Long effect
- Dexamethasone: Potency 25-30. Long effect
- Beclomethasone. potency 300-400. Local
- Fluticason: Potency 400-500. Oral
- Budesonide: Oral
NSAIDs
- side effects
- GI ulcerations –> local irritation (ion trapping) that leads to decreased PGE = Ulceration
- kidney damage –> dehydration, anaesthesia. Preexisting renal disease
- Hepatotoxicity –> Rarely (Paracetamol, carprofen)
- Platelet aggregation inhibition –> Aspirin, flunixin, tolfenamic acid, ketoprofen
- Allergic reactions
- Methaemoglobinaemia –> Paracetamol (Cat!)
- Proteoglycan synthesis inhibition (cartilage damage) –> Aspirin, ketoprofen, ibuprofen, naproxen
- Fetal damage (teratogenicity)
- Placenta retention (48-36 hours)
- Cardiotoxicity (Coxibs)
NSAIDs
- Active substances - Acidic substances:
Salicylates:
- Acetylsalicylic acid (Aspirin): Dog, farm animals
- Na salicylate
- Sulfasalozine, mesalazine: Chronic colitis
Arilpropionic acids:
- Ketoprofen (Ketofen A.U.V): Platelets! Cat: short term safity
- Vedaprofen: Horse
- Carprofen (Rimadyl A.U.V): Hepatopathy in retrivers). Carefull in combination with phenobarb. Cattle: long action.
–.> P.O, S.C, I.V
—> No cartilage damage, rare side effects (Cox-2)
—> Also for exitoc animals
Heteroaryl acetic acids:
- Diclofenac (Voltaren, Cataflam), Indomethacin. NO!
- Etodolac. Safe!
Anthranilic acids:
- Flonixin meglumin (Finadyne A.U.V): thrombocyte-aggregation inhibition, Antiendotoxic
- Tolfenamic acid: safe short term, also in cats
Butyil pyrazolidines: Phenylbotazone
Oxicams:
- Piroxicam, tenoxicam. NO!
- Meloxicam (metacam). Safe!
–> COX-2 preferential. Antiendotoxin
NSAIDs
- Pharmacological effects
- antinflammatory
- antipyretic
- analgesic
- platelet aggregation inhibition
- antiendotoxin
- antineoplastic
- spasmolytic
Glucocorticosteroids
- physiological and pathological effects –> catabolism
- stress hormone –> mobilizing hormone
- Diabetogenic (<–> insulin)
- Gluconeogenesis increase (liver) –> hyperglycaemia
–> Proteins - amino acids - GNG
–> Fats - glycerine - GNG
- Muscle atrophy, weakness
- decreased calcium absorption, incorporation –> osteoporosis
- decreased collagen synthesis –> delayed wound healing
- skin thinning, alopecia (Ca <–> Fe)
- Decreased growth
- PU/PD (ADH inhibition and psychic)
NSAIDs
- Active substances
Acidic substances:
- Salicylates, Arilpropionic acids, Heteroaryl acetic acids, Anthranilic acids, Butyl pyrazolidines, Oxicams.
Non- acidic substances:
- Anilin derivatives, metamizole derivatives
Coxibs:
- Deracoxib, Fibrocoxib, Rodenacoxib, Cimicoxib, Mevacoxib
Lokivetmab
Cytopoint
- IL-31: monoclonal antibody. Highly specific. S.C
Immunosuppression
- Mycophenolate mofetil
* Antimetabolites
- Prodrug: plasma esterase –> mycofenolic adid (per os). Inosine Monophosphate Dehydrogenase inhibitor (GMP decrease)
- Specific to T- and B-lymphocyes: De novo GTP synthesis. In other cells: Salvage pathway
- Much safer than azathiopurine (GI, BM rare)
- rarely used in vet.med
NSAIDs
- Active substances - Coxibs
COX-2 inhibitors
- Deracoxib (Dermaxx A.U.V): -meloxicam. Dog
- Fibrocoxib (Previcox A.U.V): Dog, horse. Highly selective COX-2 inhibitors
- Robenacoxib (Onsior A.U.V): Dog and Cat. Injection + tablets.
- Cimicoxib (Cimalgex A.U.V)
- Mevacoxib (Trocoxil A.U.V): Dog. Long half-life. Empty vs full stomach. Albumin binding 98%.
NSAIDs vs COBIBS
- Both: managing pain and inflammation (especially arthritis). Equivalent analgesic and antiinflammatory effect.
- GI tract: COXIBS benefits over NSAIDs in reducing perforations, ulcers etc.
- Kidney: equal
- Cardiovascular system: NSAIDs benefits
Immunosuppression
- Methotrexate
* Antimetabolites
- Folic acid antagonist
- Dihydrofolate reductase inhibitors: PABA –> dihydrofolic acid –> tetrahydrofolic acid
- Apoptosis of activated T-cells: No effect on cells in resting state
- Antineoplastics
NSAIDs
- mechanism of action
COX1 isoenzyme
- localization: stomach, kidney, platelets
- Constitutive
COX2 isoenzyme
- localization: macrophages, fibroblast
- inductive
Glucocorticoids (SAIDs)
- indications, recommended order
- local use: atopic dermatitis, otitis externa, mastitis
- single injectable dose
- asthma, RAO: inhalation
- intra articular
- ADT
- Depot injections
Immunosuppression
- Azathioprine
* Antimetabloites
- Prodrug: Mercaptopurine
- Slow release - longer effect
- I.V or Oral
- Side effects: Feline
- Application: Autoimmine disease